[Federal Register Volume 65, Number 98 (Friday, May 19, 2000)]
[Notices]
[Page 31917]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-12686]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Care Financing Administration

[HCFA-3034-N]


Medicare Program; Meeting of the Executive Committee of the 
Medicare Coverage Advisory Committee--June 6, 2000

AGENCY: Health Care Financing Administration (HCFA), HHS.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: This notice announces a public meeting of the Executive 
Committee (the Committee) of the Medicare Coverage Advisory Committee 
(MCAC). The Committee will hear reports from the Medical and Surgical 
Procedures Panel meeting of April 12 and 13, 2000, during which 
biofeedback and pelvic floor electrical stimulation in the treatment of 
urinary incontinence were deliberated. The Committee will also discuss 
presentations from interested persons regarding procedural aspects of 
future public meetings of the medical specialty panels of the MCAC. 
Notice of this meeting is given under the Federal Advisory Committee 
Act (5 U.S.C. App. 2, section 10(a)(1) and (a)(2)).

DATES:   
    The Meeting: June 6, 2000, from 8 a.m. until 3 p.m., E.D.T.
    Deadline for Presentations and Comments: May 17, 2000, 5 p.m., 
E.D.T.
    Special Accommodations: Persons attending the meeting who are 
hearing impaired and require sign language interpretation, or have a 
condition that requires other special assistance or accommodations, are 
asked to notify the Executive Secretary by May 25, 2000.

ADDRESSES:   
    The Meeting: The meeting will be held at the Baltimore Convention 
Center, One West Pratt Street, Baltimore, Maryland 21201.
    Presentations and Comments: Submit formal presentations and written 
comments to Constance A. Conrad, Executive Secretary; Office of 
Clinical Standards and Quality; Health Care Financing Administration; 
7500 Security Boulevard; Mail Stop S3-02-01; Baltimore, MD 21244.
    Website: You may access up-to-date information on this meeting at 
www.hcfa.gov/quality/8b.htm.
    Hotline: You may access up-to-date information on this meeting on 
the HCFA Advisory Committee Information Hotline, 1-877-449-5659 (toll 
free) or in the Baltimore area (410) 786-9379.

FOR FURTHER INFORMATION CONTACT: Constance A. Conrad, Executive 
Secretary, 410-786-4631.

SUPPLEMENTARY INFORMATION: On August 13, 1999, we published a notice 
(64 FR 44231) to describe the MCAC, which provides advice and 
recommendations to us about clinical issues.

Current Panel Members

    Harold C. Sox, MD (Chairperson); Thomas V. Holohan; Leslie P. 
Francis; John H. Ferguson; Robert L. Murray; Alan M. Garber; Michael D. 
Maves; Frank J. Papatheofanis; Ronald M. Davis; Daisy Alford-Smith; Joe 
W. Johnson; Robert H. Brook; Linda A. Bergthold; Randel E. Richner.

Meeting Topic

    The Committee will hear reports from the Medical and Surgical 
Procedures Panel meeting of April 12 and 13, 2000, during which 
biofeedback and pelvic floor electrical stimulation in the treatment of 
urinary incontinence. The Committee will also hear and discuss 
presentations from interested persons regarding procedural aspects of 
future public meetings of the medical specialty panels of the MCAC.

Procedure and Agenda

    This meeting is open to the public. The Committee will hear oral 
presentations from the public for approximately 1 hour. The Committee 
may limit the number and duration of oral presentations to the time 
available. If you wish to make formal presentations you must notify the 
For Further Information Contact, and submit the following by the 
Deadline for Presentations and Comments date listed in the DATES 
section of this notice: a brief statement of the general nature of the 
evidence or arguments you wish to present, the names and addresses of 
proposed participants, and an estimate of the time required to make the 
presentation. We will request that you declare at the meeting whether 
you have any financial involvement with manufacturers of any items or 
services being discussed (or with their competitors).
    After the public presentation, we will make a presentation to the 
Committee. After our presentation, the Committee will deliberate 
openly. Interested persons may observe the deliberations, but the 
Committee will not hear further comments during this time except at the 
request of the chairperson. Prior to the review of the Medical 
Specialty Panel recommendation, the Committee will allow approximately 
a 30-minute open public session for any attendee to address issues 
specific to the topic. After the open session, the members will vote 
and the Committee will make its recommendation.

    Authority: 5 U.S.C. App. 2, section 10(a)(1) and (a)(2).

(Catalog of Federal Domestic Assistance Program No. 93.774, 
Medicare-- Supplementary Medical Insurance Program)

    Dated: May 11, 2000.
Jeffrey L. Kang,
Director Office of Clinical Standards and Quality, Health Care 
Financing Administration.
[FR Doc. 00-12686 Filed 5-18-00; 8:45 am]
BILLING CODE 4120-01-P